This is an old revision of this page, as edited by Beetstra (talk | contribs) at 11:31, 6 March 2012 (Saving copy of the {{chembox}} taken from revid 478567242 of page Gusperimus for the Chem/Drugbox validation project (updated: 'CASNo').). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
Revision as of 11:31, 6 March 2012 by Beetstra (talk | contribs) (Saving copy of the {{chembox}} taken from revid 478567242 of page Gusperimus for the Chem/Drugbox validation project (updated: 'CASNo').)(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff)This page contains a copy of the infobox ({{chembox}}) taken from revid 478567242 of page Gusperimus with values updated to verified values. |
Names | |
---|---|
IUPAC name 1-Amino-19-guanidino-11-hydroxy-4,9,12-triazanonadecane-10,13-dione | |
Identifiers | |
3D model (JSmol) | |
ChEMBL | |
ChemSpider | |
KEGG | |
MeSH | gusperimus |
PubChem CID | |
UNII | |
InChI
| |
SMILES
| |
Properties | |
Chemical formula | C 17N 7H 37O 3 |
Molar mass | 387.5208 g mol |
log P | −0.933 |
Acidity (pKa) | 11.588 |
Basicity (pKb) | 2.409 |
Pharmacology | |
Routes of administration |
|
Pharmacokinetics: | |
Bioavailability | 100% |
Legal status |
|
Related compounds | |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C , 100 kPa). Infobox references |